为充分运用互联网技术培养大学生的创新能力,在对"慕课"MOOC(Massive Open Online Courses)网络教学理念的研究基础上,通过对网络学习模式进行更广泛的探索,提出"慕斯"(Mobile Open Online School,即移动在线开放校...为充分运用互联网技术培养大学生的创新能力,在对"慕课"MOOC(Massive Open Online Courses)网络教学理念的研究基础上,通过对网络学习模式进行更广泛的探索,提出"慕斯"(Mobile Open Online School,即移动在线开放校园,简称MOOS)网络教学新理念,突破单一的课程学习模式,实现网络学习的横向拓展,构建以现代大学生需求为驱动的网络学习生态系统。该文探讨基于MOOS理念构建药学网络学习平台,以期提高药学生的创新思维与能力。展开更多
The recent spring up of the antineoplastic agents and the prolonged survival bring both challenge and chance to radiological practice.Radiological methods including CT,MRI and PET play an increasingly important role i...The recent spring up of the antineoplastic agents and the prolonged survival bring both challenge and chance to radiological practice.Radiological methods including CT,MRI and PET play an increasingly important role in evaluating the efficacy of these antineoplastic drugs.However,different antineoplastic agents potentially induce different radiological signs,making it a challenge for radiological response evaluation,which depends mainly on one-sided morphological response evaluation criteria in solid tumors(RECIST)in the status quo of clinical practice.This brings opportunities for the development of radiomics,which is promising to serve as a surrogate for response evaluations of anti-tumor treatments.In this article,we introduce the basic concepts of radiomics,review the state-of-art radiomics researches with highlights of radiomics application in predictions of molecular biomarkers,treatment response,and prognosis.We also provide in-depth analyses on major obstacles and future direction of this new technique in clinical investigations on new antineoplastic agents.展开更多
文摘为充分运用互联网技术培养大学生的创新能力,在对"慕课"MOOC(Massive Open Online Courses)网络教学理念的研究基础上,通过对网络学习模式进行更广泛的探索,提出"慕斯"(Mobile Open Online School,即移动在线开放校园,简称MOOS)网络教学新理念,突破单一的课程学习模式,实现网络学习的横向拓展,构建以现代大学生需求为驱动的网络学习生态系统。该文探讨基于MOOS理念构建药学网络学习平台,以期提高药学生的创新思维与能力。
文摘The recent spring up of the antineoplastic agents and the prolonged survival bring both challenge and chance to radiological practice.Radiological methods including CT,MRI and PET play an increasingly important role in evaluating the efficacy of these antineoplastic drugs.However,different antineoplastic agents potentially induce different radiological signs,making it a challenge for radiological response evaluation,which depends mainly on one-sided morphological response evaluation criteria in solid tumors(RECIST)in the status quo of clinical practice.This brings opportunities for the development of radiomics,which is promising to serve as a surrogate for response evaluations of anti-tumor treatments.In this article,we introduce the basic concepts of radiomics,review the state-of-art radiomics researches with highlights of radiomics application in predictions of molecular biomarkers,treatment response,and prognosis.We also provide in-depth analyses on major obstacles and future direction of this new technique in clinical investigations on new antineoplastic agents.
